Figure 3 | Scientific Reports

Figure 3

From: Evaluation and comparison of pharmacokinetic profiles and safety of two extended-release buprenorphine formulations in common marmosets (Callithrix jacchus)

Figure 3

(A) Schematic of recording in home cage and movement tracing by machine learning algorithm. (B) Percent time spent moving between treatment groups for four consecutive days after administration of saline, BSR, or EXR. Baseline represents animal movement for four consecutive days before treatment. Large dots represent average, smaller dots represent individual animal per group. A representative movement trace (upper left), raster plot (lower left), and average change in movement compared to baseline (right) are shown for saline (C), BSR (D), EXR 0.05–0.01 mg/kg (E), and EXR 0.15–0.2 mg/kg (F). *P-value < 0.001.

Back to article page